Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13633
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTantisiriwat W.
dc.contributor.authorSantiwattanakul S.
dc.date.accessioned2021-04-05T03:25:10Z-
dc.date.available2021-04-05T03:25:10Z-
dc.date.issued2015
dc.identifier.issn1252208
dc.identifier.other2-s2.0-84957716993
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13633-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84957716993&partnerID=40&md5=60b202cacabbfe993878296c9877b11d
dc.description.abstractObjective: To identify the epidemiology of candida isolations in HRH Princess Maha Chakri Sirindhorn Medical Center and the sensitivity of all candida species to fluconazole. Material and Method: Two hundred of Candida albicans and other Candida species from clinical specimens were collected from microbiological department between January 2010 and April 2012. All Candida were identified by standard methods and the sensitivity of fluconazole was tested by using fluconazole E test test. Results: There were 8 species of Candida in this study including: C. albicans (n = 94), C. tropicalis (n = 66), C. glabrata (n = 11), C. guilliermondii (n = 10), C. parapsilosis (n = 9), C. zeylanoides (n = 4), C. keyfr (C. pseudotropicalis) (n = 2), C. lusitaniae (n = 1), Candida species (n = 3). The percentage of non-albicans Candida spp. was slightly higher than C. albicans (53% vs. 47%). C. tropicalis was identified as the highest percentage of all non-albicans Candida spp. Fluconazole resistant strains were detected among C. albicans (35.71%), C. tropicalis (13.85%), C. guilliermondii (20.0%), and C. zeylanoides (50.0%). The common spp. with highest percentage of resistant strain was C. albicans. Conclusion: Fluconazole could be used as the first-line antifungal for candidiasis at HRH Princess Maha Chakri Sirindhorn Medical Center. Empirical treatment with amphotericin B and stepping down to fluconazole when sensitivity suggested might be the recommendation for severe cases in our setting. © 2015, Medical Association of Thailand. All rights reserved.
dc.subjectamphotericin B
dc.subjectfluconazole
dc.subjectamphotericin B
dc.subjectantifungal agent
dc.subjectfluconazole
dc.subjectantibiotic sensitivity
dc.subjectArticle
dc.subjectCandida albicans
dc.subjectCandida glabrata
dc.subjectCandida parapsilosis
dc.subjectCandida tropicalis
dc.subjectCandida zeylanoides
dc.subjectcandidemia
dc.subjectcandidiasis
dc.subjectClavispora lusitaniae
dc.subjectKluyveromyces marxianus
dc.subjectMeyerozyma guilliermondii
dc.subjectminimum inhibitory concentration
dc.subjectnonhuman
dc.subjectprospective study
dc.subjectsensitivity analysis
dc.subjectCandida
dc.subjectcandidiasis
dc.subjecthuman
dc.subjectisolation and purification
dc.subjectmicrobial sensitivity test
dc.subjectprocedures
dc.subjectUnited States
dc.subjectuniversity hospital
dc.subjectAcademic Medical Centers
dc.subjectAmphotericin B
dc.subjectAntifungal Agents
dc.subjectCandida
dc.subjectCandida albicans
dc.subjectCandidiasis
dc.subjectFluconazole
dc.subjectHumans
dc.subjectMicrobial Sensitivity Tests
dc.subjectProspective Studies
dc.subjectUnited States
dc.titleEpidemiology of candida infections in HRH princess maha chakri sirindhorn medical center, srinakharinwirot university
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of the Medical Association of Thailand. Vol 98, (2015), p.S66-S70
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.